Healthcare Services

Global Chronic Lower Back Pain Market Report 2026–2035 Highlighting Expansion Outlook and Forecast Opportunities

March 31, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Chronic Lower Back Pain Market Between 2026 And 2030?

The chronic lower back pain market has shown consistent expansion in recent years. This market is projected to expand from $8.04 billion in 2025 to $8.41 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 4.6%. Historically, this expansion has been driven by factors such as an increasing aging population, a rising prevalence of musculoskeletal disorders, growing sedentary lifestyles, a higher incidence of workplace-related back injuries, and expanded access to diagnostic imaging.

The chronic lower back pain market is anticipated to experience consistent expansion in the coming years. This market is projected to reach $10.06 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.6%. The anticipated growth during the forecast period is driven by factors such as a rise in demand for non-invasive therapies, the increasing embrace of digital therapeutics, the widening availability of outpatient pain management services, an elevated emphasis on personalized medicine, and heightened investments in research pertaining to chronic pain. Key trends characterizing this period involve the increasing uptake of multimodal pain management strategies, a surge in the utilization of minimally invasive interventions, the expanding integration of digital tools for pain monitoring, the broadening of personalized treatment options, and a reinforced commitment to non-opioid therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9946&type=smp

What Major Drivers Are Influencing Demand In The Chronic Lower Back Pain Market?

The chronic lower back pain market is expected to be boosted by the increasing geriatric population. The geriatric population consists of older individuals aged 65 years and above. Within this demographic, age-related neurodegenerative and musculoskeletal conditions like arthritis and osteoarthritis advance rapidly, leading to weakness and painful complaints that contribute to chronic back pain and reduced physical activities. For example, according to the Administration for Community Living, a US-based government agency, in May 2024, 17.3% of the population in 2022 was 65 or older. This figure is projected to increase to 22% by 2040. Hence, the expanding geriatric population is a significant driver for the growth of the chronic lower back pain market.

Which Market Segments Are Examined In The Chronic Lower Back Pain Market Study?

The chronic lower back pain market covered in this report is segmented –

1) By Type Of Pain: Diskogenic Pain, Lumbar Spinal Stenosis, Sacroiliac Pain, Facet-Joint Pain, Radicular Pain, Muscular Pain, Other Types Of Pain

2) By Diagnosis: Clinical History, Physical Examination, Imaging Guidelines, Assessment Of Pain

3) By End-User: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Diskogenic Pain: Herniated Disc, Degenerative Disc Disease, Disc Bulge, Lumbar Spinal Stenosis

2) By Lumbar Spinal Stenosis: Central Stenosis, Lateral Stenosis

3) By Sacroiliac Pain: Sacroiliac Joint Dysfunction, Inflammatory Conditions

4) By Facet-Joint Pain: Facet Joint Syndrome, Osteoarthritis Of The Facet Joints

5) By Radicular Pain: Sciatica, Nerve Root Compression

6) By Muscular Pain: Muscle Strain, Muscle Spasm

7) By Other Types Of Pain: Myofascial Pain Syndrome, Spondylolisthesis, Osteoporosis-Related Pain

How Are Trends Impacting The Chronic Lower Back Pain Market?

Leading companies operating in the chronic lower back pain market are developing products incorporating advanced technologies, like BurstDR SCS technology, to present novel alternatives for patients. BurstDR SCS technology is a proprietary spinal cord stimulation (SCS) therapy that functions by applying mild electrical pulses to alter pain signals as they move from the spinal cord towards the brain. For instance, in May 2023, Abbott Laboratories, a US-based medical device company, secured FDA approval for its Spinal Cord Stimulation (SCS) devices, which include the Proclaim SCS Family and Eterna SCS System, for the management of chronic back pain. Abbott’s SCS devices utilize its proprietary BurstDR stimulation waveform, a superior treatment designed to more accurately simulate how pain signals travel to the brain and to address the emotional distress linked to pain, contrasting with traditional tonic stimulation.

Who Are The Primary Competitors In The Chronic Lower Back Pain Market?

Major companies operating in the chronic lower back pain market are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals plc, Merck Corporation, Vertebral Technologies Inc., Medtronic plc, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., SpineThera Inc., Dr. Reddy’s Laboratories Ltd., Celgene Corporation, Axsome Therapeutics Inc., Mesoblast Limited, Frontier Biotechnologies Inc., Eli Lilly and Company, Persica Pharmaceuticals, Abbott Laboratories, Hisamitsu Pharmaceutical Co. Inc., Ipsen S.A., Daiichi Sankyo Company Ltd., Zimmer Biomet Holdings Inc., Novartis International AG, Janssen Pharmaceuticals Inc., Insys Therapeutics Inc., Collegium Pharmaceutical Inc., Cara Therapeutics Inc.

Read the full chronic lower back pain market report here:

https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Chronic Lower Back Pain Market?

North America was the largest region in the chronic lower back pain market in 2025. The regions covered in the chronic lower back pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Chronic Lower Back Pain Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9946&type=smp

Browse Through More Reports Similar to the Global Chronic Lower Back Pain Market 2026, By The Business Research Company

Liver Health Supplements Global Market Report

https://www.thebusinessresearchcompany.com/report/liver-health-supplements-global-market-report

Hepatitis Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

Fatty Liver Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795